Both in Pharmaceuticals
Aprea Therapeutics vs KALA BIO
Over the past year APRE returned −49.0% and KALA returned −99.5%; their daily moves had a correlation of 0.14.
APRE −49.0% KALA −99.5%Growth of $1, one year, split-adjusted
| Metric | APRE | KALA |
|---|---|---|
| Price | $0.7696 | $0.5033 |
| Market cap | $9.7M | $9.7M |
| Today | +2.37% | +11.79% |
| 1 month | −8.2% | −27.1% |
| 6 months | +4.1% | −94.1% |
| Year to date | −9.8% | −98.2% |
| 1 year | −47.3% | −99.9% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 1,868.9× | — |
| Net cash | $41.2M | $7.2M |
| Dividend yield | — | — |
| Volatility (60d) | 77.4% | 118.7% |
| Short % of float | 6.4% | 2.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).